Prolonged decrease in blood pressure after atrial natriuretic peptide infusion in essential hypertension: a new...

Area of Science:

• Cardiology
• Endocrinology
• Nephrology

Background:

• Essential hypertension is a prevalent cardiovascular risk factor.
• Atrial natriuretic peptide (ANP) plays a role in regulating blood pressure and sodium balance.
• Understanding ANP's therapeutic potential is crucial for hypertension management.

Purpose of the Study:

• To investigate the anti-hypertensive effects of alpha-human ANP (102-126) infusion in patients with essential hypertension.
• To assess the impact of ANP on blood pressure, sodium excretion, and hormonal profiles under varying sodium diets.

Main Methods:

• A randomized, cross-over study involving eight patients with mild to moderate essential hypertension.
• Infusion of alpha-human ANP (102-126) or placebo for 60 minutes on separate days with controlled low and high sodium diets.
• Measurements included blood pressure, plasma ANP levels, urinary sodium excretion, packed cell volume, plasma renin activity, and plasma aldosterone.

Main Results:

• ANP infusion caused a significant, sustained decrease in blood pressure, lasting up to 4 hours post-infusion, irrespective of sodium intake.
• Urinary sodium excretion increased during ANP infusion but decreased below placebo levels in the post-infusion period.
• Plasma aldosterone levels were elevated post-ANP infusion, while plasma renin activity remained unchanged.

Conclusions:

• Alpha-human ANP exhibits potent and sustained anti-hypertensive effects in patients with essential hypertension.
• The blood pressure-lowering effect of ANP is not significantly influenced by dietary sodium levels.
• ANP influences sodium balance and aldosterone secretion, suggesting complex interactions in cardiovascular regulation.